Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06423794 · ClinicalTrials.gov registry record · Phase 2
BHV-7000 Open-Label Extension Bipolar Mania Study
A Phase 2 study, sponsored by Biohaven Therapeutics.
- Terminated
- Registry status
- Phase 2
- Development phase
- 94
- Enrollment target
NCT06423794: Clinical Trial Phase 2 study, sponsored by Biohaven Therapeutics.
NCT06423794 is a Phase 2 study that was terminated before completion, run by Biohaven Therapeutics. The registered enrollment target is 94 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (29% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06423794, a Phase 2 study, was terminated before completion, sponsored by Biohaven Therapeutics.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 94 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the long-term safety and tolerability of BHV-7000 in subjects with bipolar I disorder.
Primary Outcome
To assess the safety and tolerability of BHV-7000. This objective will be measured by assessing the number of unique subjects with grade 3 or 4 laboratory abnormalities.
Interventions
- DRUG BHV-7000
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 94 participants |
| Start Date | 2024-06-24 |
| Est. Completion | 2025-04-25 |
| Phase | Phase 2 |
Why NCT06423794 stopped before completion
NCT06423794 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 94 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (29% lower).
The record links to 0 conditions, and to 1 intervention - of which BHV-7000 is the first listed.
NCT06423794 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06423794 about?
NCT06423794 is a clinical study titled "BHV-7000 Open-Label Extension Bipolar Mania Study". The purpose of this study is to evaluate the long-term safety and tolerability of BHV-7000 in subjects with bipolar I disorder.
What is the current status of trial NCT06423794?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 94 participants. The study started on 2024-06-24. Estimated completion is 2025-04-25.
What interventions are being tested in trial NCT06423794?
The interventions under investigation include: BHV-7000 (DRUG).
Who is sponsoring clinical trial NCT06423794?
This trial is sponsored by Biohaven Therapeutics, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06423794's enrollment target sits among peer trials
94 764th of 2000 higher than 1,235 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03747146 · 94 participants · NA
Enhanced Recovery After Surgery (ERAS) Total Knee Replacement (TKR) With a Transitional Pain Service
- NCT04061421 · 94 participants · Phase 1
Active Myeloid Target Compound Combinations in MDS/MPN Overlap Syndromes Overlap Syndromes (ABNL-MARRO)
- NCT04205968 · 94 participants · Phase 2
Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
- NCT04464759 · 94 participants · Phase 1
A Study of Nivolumab and Hydroxychloroquine or Nivolumab/Ipilimumab and Hydroxychloroquine in Advanced Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI